Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes
Sign Up to like & getrecommendations! Published in 2017 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.01.010
Abstract: Background Evaluation of antithrombotic treatments for acute coronary syndromes (ACS) requires balancing ischemic and bleeding risks to assess net benefit. We sought to compare the relative effects of ischemic and bleeding events on mortality. Methods… read more here.
Keywords: ischemic bleeding; bleeding events; spontaneous ischemic; major bleeding ... See more keywords
Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2019.04.046
Abstract: BACKGROUND The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) trial found clinical benefit of low-dose rivaroxaban plus aspirin, but at the expense of increased bleeding risk in patients with stable vascular disease. OBJECTIVES This… read more here.
Keywords: enrichment criteria; risk; ischemic bleeding; compass eligible ... See more keywords
Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI
Sign Up to like & getrecommendations! Published in 2020 at "Platelets"
DOI: 10.1080/09537104.2020.1774052
Abstract: Abstract The benefits and harms of dual antiplatelet therapy (DAPT) continuation with aspirin and clopidogrel beyond 1 year after percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation for high ischemic or bleeding risk patients… read more here.
Keywords: risk; ischemic bleeding; high risk; year ... See more keywords
461Modulation of ischemic and bleeding risk by peripheral artery disease after an acute coronary syndrome
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz747.0120
Abstract: Peripheral artery disease (PAD) is associated with heightened ischemic and bleeding risk in patients with acute coronary syndrome (ACS). With this study from real-life patients, we try to analyze the balance between ischemic and bleeding… read more here.
Keywords: risk; ischemic bleeding; without pad; bleeding risk ... See more keywords
Activated Clotting Time to Guide Heparin Dosing in Non–ST-Segment–Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes Insights From the TAO Trial
Sign Up to like & getrecommendations! Published in 2018 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.118.006084
Abstract: Background— Monitoring anticoagulation with activated clotting time (ACT) has been proposed to reduce ischemic or bleeding events. However, the value of using ACT to improve outcomes is uncertain. This study sought to determine the relationship… read more here.
Keywords: heparin; trial; ischemic bleeding; act ... See more keywords